🚀 VC round data is live in beta, check it out!

🇪🇺

Multiples Europe 100 Index

Curated by Multiples, this index tracks the 100 largest publicly listed European companies.

Explore the Multiples Europe 100 Index

100

public companies tracked

$15.2T

cumulative enterprise value

3.5x

median EV/NTM revenue multiple

3%

median NTM/LTM revenue growth

Index Performance

This chart shows the weighted market cap evolution over time for the Multiples Europe 100 Index constituents, indexed to 0% at the beginning of the period.

+0.0%

Multiples Europe 100 Index

Data as of 01 April 2026. Underlying financial data from FactSet and Morningstar. S&P 500 and NASDAQ data sourced from Yahoo Finance.

Key Index Metrics

This chart shows the median evolution over time of key valuation metrics for the Multiples Europe 100 Index constituents.

Valuation Benchmarks

This chart shows the regression relationship between valuation metrics across companies in the Multiples Europe 100 Index.

x-axis:
y-axis:

Data as of April 1, 2026. Companies with EV multiples above 50x and y-axis values above 250% are considered non-meaningful and excluded from calculation.

Company Rankings

This chart shows company rankings by selected metric within the Multiples Europe 100 Index.

Metric:

Data as of April 1, 2026. Companies with EV multiples above 50x and y-axis values above 300% are considered non-meaningful and excluded from calculation.

Companies Side-by-Side

Compare key metrics between companies in the Multiples Europe 100 Index.

1:
2:
3:
Metric
ASML
Roche
AstraZeneca
Market Cap
$549B
$377B
$317B
EV/Revenue (NTM)
11.9x
5.1x
5.3x
EV/Gross Profit (NTM)
22.3x
6.8x
6.4x
EV/EBITDA (NTM)
29.8x
12.6x
14.5x
EV/FCF (NTM)
49.3x
21.4x
29.0x
Revenue Growth
13%
-1%
7%
Gross Margin (NTM)
53%
75%
82%
EBITDA Margin (NTM)
40%
40%
37%
FCF Margin (NTM)
24%
24%
18%
Rule of 40
54%
39%
44%
Rule of X
77%
37%
55%

Data as of April 1, 2026.

Cumulative Metrics

This chart shows the cumulative sum of selected metrics across all companies in the Multiples Europe 100 Index, over time.

Index Methodology

Similar to the NASDAQ 100 Index, the Multiples Europe 100 Index employs a modified market capitalization weighting scheme.

The weight process uses company-level weights, which are derived using company market capitalization.

Company weights are evaluated based on two rules:

Rule 1

No company's weight may exceed 24%.

Rule 2

The aggregate weight of the companies whose weights exceed 4.5% may not exceed 48%.

If neither rule is 'violated', then no adjustments are made. Only in cases where either or both of the rules are 'violated', weight adjustments are made according to a two-stage adjustment process.

Rule 1 adjustment

If no company's initial weight exceeds 24% of the Index, initial weights are used as Rule 1 weights without adjustment. Otherwise, initial weights are adjusted such that no company's weight may exceed 20% of the Index.

Rule 2 adjustment

If the aggregate weight of the companies whose Rule 1 weights exceeds 4.5% and does not exceed 48%, Rule 1 weights are used as the final weights. Otherwise, Rule 1 weights are adjusted such that:

  • The aggregate weight of the companies whose Rule 1 weights exceeded 4.5% is set to 40%.
  • Companies with Rule 1 weights below 4.5% may also have their weights adjusted to keep the initial rank order of all companies.

If the two-stage rule process results in a 'violation' of the weighting rules as previously detailed, then the process is repeated until the company weights meet the rule system.

Companies Included in the Multiples Europe 100 Index

This index tracks the 100 largest publicly listed European companies.

NL
4.6%
$1,423
+115%
$549B
11.9x
13%
53%
40%
24%
54%
$887K
CH
3.2%
$59
+43%
$377B
5.1x
-1%
75%
40%
24%
39%
$710K
GB
2.7%
$204
+42%
$317B
5.3x
7%
82%
37%
18%
44%
$623K
CH
2.6%
$162
+36%
$310B
5.7x
5%
79%
40%
23%
41%
$753K
GB
2.5%
$18
+58%
$301B
3.5x
3%
$334K
FR
2.5%
$596
+6%
$296B
3.4x
-1%
67%
30%
16%
31%
$448K
CH
2.3%
$104
-7%
$268B
3.0x
-3%
46%
20%
11%
18%
$428K
FR
2.0%
$2,254
-18%
$236B
11.1x
5%
71%
45%
26%
53%
$31M
FR
2.0%
$437
-2%
$233B
4.4x
3%
74%
24%
16%
29%
$553K
GB
2.0%
$41
+27%
$232B
0.9x
7%
41%
20%
8%
30%
$3M
DE
1.9%
$191
-35%
$223B
4.6x
7%
74%
33%
25%
43%
$399K
DE
1.7%
$260
+11%
$202B
2.5x
5%
39%
19%
11%
24%
$289K
ES
1.6%
$62
+14%
$193B
3.8x
7%
59%
29%
16%
36%
$284K
DE
1.5%
$37
+2%
$180B
2.4x
1%
40%
18%
43%
$707K
FR
1.5%
$307
+30%
$173B
3.6x
6%
43%
22%
12%
30%
$298K
ES
1.5%
$12
+65%
$171B
6.4x
0%
57%
$371K
FR
1.4%
$79
+35%
$169B
1.1x
1%
26%
24%
8%
25%
$2M
DK
1.4%
$37
-44%
$166B
4.1x
-7%
78%
48%
19%
40%
$702K
FR
1.4%
$207
+22%
$163B
1.6x
8%
16%
14%
6%
24%
$550K
DE
1.4%
$424
+1%
$161B
0.7x
2%
9%
5%
50%
$1M
CH
1.4%
$88
+60%
$160B
4.4x
10%
42%
22%
13%
32%
$297K
FR
1.4%
$385
+43%
$160B
3.8x
10%
28%
22%
14%
36%
$18M
GB
1.4%
$98
+65%
$160B
2.9x
4%
46%
46%
14%
51%
$941K
DE
1.3%
$186
+139%
$159B
2.8x
12%
21%
16%
11%
27%
$441K
BE
1.3%
$79
+21%
$154B
3.4x
6%
57%
36%
20%
44%
$415K
ES
1.3%
$23
+24%
$153B
3.9x
1%
58%
36%
2%
42%
$1M
GB
1.3%
$70
-2%
$153B
3.0x
0%
47%
23%
12%
25%
$500K
CH
1.1%
$343
+20%
$134B
2.6x
6%
24%
1%
21%
$1M
GB
1.1%
$124
+9%
$132B
21.8x
21%
98%
46%
30%
68%
$481K
GB
1.1%
$61
+40%
$132B
5.0x
-2%
79%
48%
32%
51%
$755K
GB
1.1%
$16
+56%
$131B
4.2x
10%
22%
22%
17%
28%
$659K
ES
1.0%
$22
+56%
$124B
4.6x
6%
$355K
CH
1.0%
$40
+25%
$123B
7.0x
6%
$440K
IT
1.0%
$80
+37%
$121B
7.7x
3%
65%
$419K
SE
1.0%
$38
+24%
$118B
18.1x
0%
147%
10%
96%
$1M
FR
1.0%
$251
-14%
$116B
3.5x
8%
58%
24%
13%
35%
$605M
FR
1.0%
$201
-3%
$116B
3.9x
2%
65%
31%
10%
35%
$478K
FR
1.0%
$106
+23%
$116B
4.5x
4%
$443K
GB
1.0%
$29
+45%
$115B
3.0x
1%
75%
34%
17%
38%
$650K
IT
1.0%
$11
+30%
$115B
2.0x
0%
30%
2%
29%
$1M
CH
1.0%
$19
+9%
$113B
4.0x
7%
66%
28%
16%
34%
$630K
IT
0.9%
$6
+19%
$112B
3.4x
2%
60%
$342K
FR
0.9%
$44
-19%
$107B
2.1x
3%
72%
30%
17%
34%
$725K
NL
0.9%
$49
+3%
$105B
8.3x
35%
43%
11%
16%
48%
$278K
SE
0.9%
$507
-17%
$104B
4.1x
11%
33%
17%
19%
30%
$3M
FR
0.9%
$569
+9%
$103B
$429K
CH
0.9%
$719
-3%
$102B
1.6x
6%
14%
8%
-12%
$1M
GB
0.9%
$7
+40%
$101B
0.7x
-2%
36%
21%
7%
19%
$2M
FR
0.8%
$46
-3%
$97B
1.8x
-29%
15%
6%
-13%
$1M
SE
0.8%
$19
+22%
$93B
5.1x
-1%
43%
27%
17%
30%
$341K
GB
0.8%
$18
+27%
$92B
5.2x
10%
44%
-11%
52%
$771K
FR
0.7%
$159
+12%
$88B
1.2x
0%
18%
7%
20%
$315K
GB
0.7%
$30
+27%
$86B
2.1x
12%
13%
14%
6%
30%
$357K
DE
0.7%
$1,865
+8%
$85B
4.8x
42%
23%
23%
13%
69%
$403K
DE
0.7%
$13
-5%
$84B
1.1x
-8%
13%
10%
18%
$2M
CH
0.7%
$7
+116%
$82B
0.5x
2%
7%
7%
2%
10%
$2M
NO
0.7%
$32
+40%
$80B
0.9x
1%
47%
41%
7%
45%
$4M
FR
0.7%
$33
+56%
$80B
1.4x
-1%
20%
20%
1%
21%
$867K
GB
0.7%
$6
+45%
$79B
4.2x
3%
43%
$428K
NL
0.7%
$27
+39%
$79B
9.7x
2%
48%
$430K
ES
0.7%
$11
+46%
$79B
6.7x
4%
62%
$411K
GB
0.6%
$1
+30%
$75B
3.8x
8%
$439K
SE
0.6%
$36
+27%
$73B
1.8x
-3%
24%
16%
7%
17%
$533K
IT
0.6%
$23
+59%
$69B
0.9x
3%
41%
21%
6%
29%
$3M
DE
0.6%
$51
+53%
$66B
3.8x
10%
43%
32%
9%
40%
$298K
IT
0.5%
$363
-21%
$64B
7.4x
3%
52%
39%
19%
45%
$1M
DE
0.5%
$34
+26%
$64B
5.5x
0%
$427K
DE
0.5%
$56
+29%
$63B
0.9x
3%
14%
13%
4%
17%
$159K
SE
0.5%
$18
+33%
$63B
21.6x
0%
54%
$440K
DE
0.5%
$145
+3%
$63B
3.0x
0%
59%
28%
14%
27%
$391K
GB
0.5%
$35
-36%
$62B
5.3x
3%
40%
25%
47%
$348K
FR
0.5%
$82
+55%
$61B
1.4x
1%
39%
$507K
FR
0.5%
$20
+6%
$61B
6.3x
0%
45%
$408K
GB
0.5%
$8
+19%
$60B
2.0x
5%
$374K
FR
0.5%
$293
+4%
$60B
2.3x
7%
30%
16%
9%
23%
$27M
IT
0.5%
$40
+8%
$60B
0.8x
2%
8%
3%
48%
$1M
DK
0.5%
$252
+17%
$60B
1.6x
11%
29%
12%
6%
29%
$257K
DE
0.5%
$97
+14%
$59B
0.8x
2%
19%
15%
3%
17%
$966K
GB
0.5%
$116
-26%
$58B
5.1x
6%
89%
51%
31%
54%
$455K
DE
0.5%
$22
+25%
$58B
0.6x
1%
27%
12%
-2%
15%
$1M
DE
0.5%
$65
+7%
$57B
0.8x
-1%
21%
12%
3%
13%
$897K
NL
0.5%
$225
+22%
$57B
4.8x
10%
59%
40%
25%
50%
$381K
DE
0.5%
$112
0%
$56B
0.5x
1%
21%
14%
3%
16%
$549K
FR
0.5%
$20
+39%
$54B
1.0x
5%
33%
11%
40%
$374K
BE
0.5%
$286
+54%
$54B
5.5x
8%
75%
35%
24%
44%
$903K
GB
0.5%
$84
+24%
$54B
3.8x
-8%
62%
28%
15%
18%
$539K
GB
0.5%
$55
+151%
$54B
5.7x
11%
63%
65%
14%
79%
$1M
DE
0.4%
$47
-13%
$53B
1.8x
4%
40%
21%
10%
24%
$363K
FR
0.4%
$82
-7%
$52B
1.9x
1%
51%
18%
10%
21%
$359K
BE
0.4%
$130
+39%
$51B
2.9x
7%
$381K
SE
0.4%
$41
+90%
$51B
3.9x
4%
39%
25%
14%
36%
$329K
GB
0.4%
$23
+59%
$51B
3.3x
5%
$255K
NL
0.4%
$72
+42%
$51B
5.1x
2%
59%
16%
8%
20%
$445K
GB
0.4%
$30
-12%
$50B
1.1x
9%
10%
5%
19%
$78K
CH
0.4%
$168
-11%
$49B
1.3x
1%
14%
3%
7%
$3M
NL
0.4%
$88
-3%
$49B
1.8x
4%
55%
23%
10%
30%
$388K
CH
0.4%
$255
+37%
$49B
5.7x
10%
58%
28%
21%
39%
$315K
DE
0.4%
$267
-18%
$49B
7.5x
3%
59%
59%
33%
46%
$546K
DE
0.4%
$54
+5%
$48B
1.0x
1%
26%
12%
4%
15%
$630K
CH
0.4%
$86
-26%
$48B
2.8x
1%
36%
25%
12%
28%
$313K

Explore More Indexes

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial